ResearcherUniversity Hospital Southampton NHS Foundation TrustActive in the last 2 years
Declan McDonnell
Matched on ORCID iD 0000-0001-9088-9875; OpenAlex author ID A5087163858. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 6
2022: 1 paper · 2023: 2 papers · 2024: 1 paper · 2025: 2 papers · 2026: 1 paper
Papers 7
- Citrulline and Faecal Elastase 1 as a Combined Diagnostic Biomarker for Pancreatic Ductal Adenocarcinoma Co-author DOI 10.2139/ssrn.7472539↗
- Metabolite Changes Associated with Resectable Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers17071150↗
- Physical Activity and Incident Pancreatic Cancer: Results From the UK Biobank Prospective Cohort. Co-author DOI 10.7759/cureus.78040↗
- The role of aspirin in the prevention of pancreatic cancer: A nested case-control study in the UK Biobank. Co-author DOI 10.1016/j.pan.2024.08.005↗
- Elevated Glycated Haemoglobin (HbA1c) Is Associated with an Increased Risk of Pancreatic Ductal Adenocarcinoma: A UK Biobank Cohort Study. Co-author DOI 10.3390/cancers15164078↗
- Utilising Pancreatic Exocrine Insufficiency in the Detection of Resectable Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers15245756↗
- DEPEND study protocol: early detection of patients with pancreatic cancer - a pilot study to evaluate the utility of faecal elastase-1 and 13C-mixed triglyceri… First author DOI 10.1136/bmjopen-2021-057271↗
Closest collaborators
The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zaed Z. R. Hamady · 7 shared papers, 2022–2026 · strength 1.83
- Paper Physical Activity and Incident Pancreatic Cancer: Results From the UK Biobank Prospective Cohort. DOI 10.7759/cureus.78040↗
- Paper The role of aspirin in the prevention of pancreatic cancer: A nested case-control study in the UK Biobank. DOI 10.1016/j.pan.2024.08.005↗
- Paper Citrulline and Faecal Elastase 1 as a Combined Diagnostic Biomarker for Pancreatic Ductal Adenocarcinoma DOI 10.2139/ssrn.7472539↗
- Paul R. Afolabi · 4 shared papers, 2022–2026 · strength 0.95
- Paper Citrulline and Faecal Elastase 1 as a Combined Diagnostic Biomarker for Pancreatic Ductal Adenocarcinoma DOI 10.2139/ssrn.7472539↗
- Paper Metabolite Changes Associated with Resectable Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers17071150↗
- Paper Utilising Pancreatic Exocrine Insufficiency in the Detection of Resectable Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers15245756↗
- Umar H.K. Niazi · 2 shared papers, 2025–2026 · strength 0.57
- Borna Ali Assarian · 1 shared paper, 2025 · strength 0.37
- George R. Buckland · 1 shared paper, 2024 · strength 0.31
- Adam Enver Frampton · 1 shared paper, 2023 · strength 0.20
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.